Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Nicolas Ferry"'
Autor:
Bernd Gansbacher, Michele Lipucci di Paola, Nicolas Ferry, Ilona Reischl, Paula Salmikangas, Margarida Menezes-Ferreira, Dariusz Sladowski, Patrick Celis, Tomáš Boráň, Hartmut Krafft
Publikováno v:
Human Gene Therapy Clinical Development. 28:126-135
The research and development of advanced therapy medicinal products (ATMPs) has been active in Europe and worldwide during recent years. Yet, the number of licensed products remains low. The main expected legal change in the near future in the Europe
Autor:
Patrick Celis, Sol Ruiz, Nicolas Ferry, Paula Salmikangas, Ilona Reischl, Matthias Renner, Egbert Flory, Margarida Menezes-Ferreira, Martina Schuessler-Lenz
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9783319186177
With the release of Regulation 1394/2007, a new framework for gene and cell therapy medicinal products and tissue-engineered products was established in the European Union. For all three product classes, called advanced therapy medicinal products, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73f7da5170eebb988cd5273d403d9528
https://doi.org/10.1007/978-3-319-18618-4_6
https://doi.org/10.1007/978-3-319-18618-4_6
Autor:
Blandine Gri, Sophie Gaillard, Nicolas Ferry, Julie Clar, A. Stefanutti, Alison Creneguy, Tuan Huy Nguyen, Fabienne Rajas, Elodie Mutel, Gilles Mithieux, Olivier Beuf
Publikováno v:
Human Molecular Genetics
Human Molecular Genetics, Oxford University Press (OUP), 2015, 24 (8), pp.2287-2296. ⟨10.1093/hmg/ddu746⟩
Human Molecular Genetics, 2015, 24 (8), pp.2287-2296. ⟨10.1093/hmg/ddu746⟩
Human Molecular Genetics, Oxford University Press (OUP), 2015, 24 (8), pp.2287-2296. ⟨10.1093/hmg/ddu746⟩
Human Molecular Genetics, 2015, 24 (8), pp.2287-2296. ⟨10.1093/hmg/ddu746⟩
Glycogen storage disease type 1a (GSD1a) is a rare disease due to the deficiency in the glucose-6-phosphatase (G6Pase) catalytic subunit (encoded by G6pc), which is essential for endogenous glucose production. Despite strict diet control to maintain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be6718902b4472ba0c5f204f5d4bc919
https://www.hal.inserm.fr/inserm-01350897/document
https://www.hal.inserm.fr/inserm-01350897/document
Autor:
Patrick Celis, Martina Schüßler-Lenz, Egbert Flory, Nicolas Ferry, Ilona Reischl, Paula Salmikangas, Pieter A. Doevendans, Marit Hystad, Claire Beuneu
Publikováno v:
Transfusion Medicine and Hemotherapy, 42(3), 194. S. Karger AG
On September 11, 2014, a workshop entitled ‘Advanced Therapy Medicinal Products: How to Bring Cell-Based Medicinal Product Successfully to the Market' was held at the 47th annual meeting of the German Society for Transfusion Medicine and Immunohema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a63e92d43bf2009a494f5bb10d72fe01
https://dspace.library.uu.nl/handle/1874/331913
https://dspace.library.uu.nl/handle/1874/331913
Autor:
Marta Bellodi-Privato, Virginie Pichard, Dominique Aubert, Didier Trono, Tuan Huy Nguyen, Anne Myara, Nicolas Ferry
Publikováno v:
Molecular Therapy. 12(5):852-859
Crigler-Najjar type 1 disease (CN-1) is a genetic disorder characterized by high levels of unconjugated bilirubin due to the absence of hepatic UDPglucuronosyltransferase (UGT1) activity. Here we show that in vivo neonatal hepatocyte transduction wit
Autor:
Virginie Pichard, Nicolas Ferry
Publikováno v:
Life Sciences. 76:3057-3068
Cyproterone acetate (CPA) is a synthetic antiandrogenic compound which is widely used in clinic but suspected to be hepatocarcinogenic. CPA is also mitogenic in rat liver. Using genetic labeling of dividing cells, we examined whether hepatocytes divi
Autor:
Anne Myara, François Trivin, Dominique Aubert, Marta Bellodi-Privato, Nicolas Ferry, Virginie Pichard
Publikováno v:
Hepatology. 42:431-438
Crigler-Najjar type 1 disease (CN1) is a rare inherited metabolic disease characterized by complete absence of hepatic UDP-glucuronosyl transferase (UGT1), resulting in high levels of unconjugated bilirubin. CN1 is an attractive candidate disease for
Publikováno v:
Hepatology. 35:281-288
Genetic labeling using recombinant retroviruses is a powerful strategy for the study of cell lineage in the liver. However, this type of vector is only able to infect dividing cells. The synthetic steroid cyproterone acetate (CPA) is mitogenic and ca
Publikováno v:
Biochemical and Biophysical Research Communications. 286:929-935
Recombinant retroviral vectors are attractive tools for achieving sustained expression of a therapeutic gene in the liver. However, cell division is required for efficient transduction with these vectors. Here we report that two widely used liver mit
Autor:
Nicolas Ferry, Olivier Kitten
Publikováno v:
Liver. 18(6)
Aims/background We studied the fate of hepatocytes in the rat liver after D-galactosamine injury by genetic labeling using recombinant retroviruses carrying the Escherichia coli lacZ gene coupled to a nuclear localization signal. Methods Hepatocytes